🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

US lawmakers urge SEC to probe Elon Musk's claims over death of lab monkeys used in Neuralink research

Published 27/11/2023, 12:14 pm
© Reuters.  US lawmakers urge SEC to probe Elon Musk's claims over death of lab monkeys used in Neuralink research
TSLA
-

Four members of the US House of Representatives are calling for an investigation by the Securities and Exchange Commission (SEC) into Elon Musk's statements concerning the welfare of animals used in experiments by his company, Neuralink.

The SEC alleges that Musk made misleading claims about the deaths of 12 macaque monkeys used in research for the brain-chip interface company.

These allegations follow a report by WIRED highlighting serious animal welfare concerns and possible misinformation from Musk about the experiments conducted at a primate centre in California between 2018 and 2020.

Surgical complications

The lawmakers, led by US Representative Earl Blumenauer, assert that Musk's assertions about the animal subjects not dying due to Neuralink implants and being close to death already are false.

They contend that these statements, made in a September post on the social media platform X (formerly Twitter), might constitute a violation of SEC rules against material omissions and misstatements in securities transactions.

These claims come amidst revelations from a WIRED investigation that found multiple instances of suffering and death among the monkeys due to surgical complications linked to Neuralink's implant procedures.

Musk's history with SEC

This request for investigation builds on Musk's history with the SEC, including a 2018 case where he was charged with securities fraud over misleading tweets about Tesla (NASDAQ:TSLA).

The SEC is also involved in a separate inquiry related to Musk's acquisition of Twitter.

Neuralink, valued at approximately US$5 billion, recently raised more than US$280 million in funding.

The lawmakers emphasise the need for accurate information for investors, particularly given the scale of investments and Musk's track record.

They argue that the integrity of information is vital, citing the 'fraud on the market' theory upheld by the Supreme Court in a 2014 case against Halliburton (NYSE:HAL).

Musk has not responded to inquiries regarding these allegations, and a spokesperson for the University of California, Davis, overseeing the primate centre, declined to comment. The SEC has yet to announce any official investigation into the matter.

Read more on Proactive Investors AU

Disclaimer

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.